This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Samantha Shaddock

Before joining TheStreet.com in June 2007, Shaddock spent six years at The Dallas Morning News, where she worked as a copy editor and helped launch Quick, a publication for young commuters. She received her English degree from the University of Texas at Arlington.

Samantha Shaddock
By This Author:
« Back
Page 1 of 21
Article

Health Stock Winners and Losers: Bristol, Glaxo

By Samantha Shaddock

Bristol announces it will reaffirm its earnings guidance, and Glaxo acquires a 16% stake in South African firm Aspen Pharmacare.

03:12PM 05/12/09

Article

Health Winners and Losers: AstraZeneca

By Samantha Shaddock

AstraZeneca's blood-thinner outperforms Plavix in a late-stage trial, and Baxter's heparin is being investigated, according to a report.

05:26PM 05/11/09

Article

AT&T Near Deal to Buy Alltel Assets: Report

By Samantha Shaddock

AT&T is reportedly close to a $2.5 billion deal to buy pieces of Alltel Corp. from Verizon.

05:04PM 05/08/09

Article

Chips Pummeled; Nvidia Swings to Loss

By Samantha Shaddock

Widely held semiconductor stocks get a blistering, and Nvidia swings to a loss.

06:35PM 05/07/09

Article

Google's Schmidt: Why Would I Leave Apple's Board?

By Samantha Shaddock

Google's CEO says he doesn't plan to resign from Apple's board despite a federal antitrust investigation.

06:26PM 05/07/09

Article

Glaxo Unloads U.S. Wellbutrin Rights for $510M

By Samantha Shaddock

GlaxoSmithKline is divesting its U.S. rights to Wellbutrin, sales of which have slipped 70%, as part of its strategy to reshape its U.S. business.

06:08PM 05/06/09

Article

Genentech's Avastin Gets Faster OK for Brain Cancer

By Samantha Shaddock

Genentech says the FDA has granted accelerated approval of its drug Avastin to treat a type of brain cancer.

06:03PM 05/06/09

Article

Chip Stocks: Intel, Atmel Get Soggy

By Samantha Shaddock

Investors dunk Intel in the red, and Atmel gets downgraded amid disappointing quarterly sales.

05:30PM 05/06/09

Article

Tech Winners and Losers: Microsoft Cuts

By Samantha Shaddock

Microsoft reportedly follows through on cuts announed in January.

06:17PM 05/05/09

Article

Intel, Other Chips Lead Tech Higher

By Samantha Shaddock

Chip stocks are leading the tech sector higher, with Intel and AMD among the biggest winners.

03:32PM 05/04/09

« Back
Page 1 of 21

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs